Hospital

This approach may help prevent premature deaths attributed to preventable or treatable cardiovascular disease.

These heat-not-burn cigarettes are incorrectly assumed to be healthier than traditional tobacco cigarettes.

The diabetes/weight loss drug has surged in popularity, and new trials are evaluating it for certain pediatric patients.

There are 2 features of weight loss interventions which are most likely to improve weight loss outcomes—having access to professional health coaches and social support from other users.

The company will discontinue the development and commercialization of aducanumab-avwa (Aduhelm) for intravenous use and will terminate the ENVISION clinical study.

In December 2023, the FDA granted expanded indications for bempedoic acid and bempedoic acid plus ezetimibe in the treatment of primary hyperlipidemia.

The diabetes/weight loss drug is be evaluated in trials for pediatric patients who are at least 10 years of age.

Survival rates were similar between non-Hispanic African American and non-Hispanic White patients who received treatment, indicating a need to address barriers to multiple myeloma treatment and racial disparities.

Daratumumab and hyaluronidase-fihj in combination with other therapies was previously approved by the FDA in May 2020 for 8 indications in multiple myeloma.

However, different recommendations may actually be valuable, as different countries have different population-based needs.

Supplementation during pregnancy also reduced communication warning behaviors in children who developed autism compared to the children of women who did not take supplements.

Creating a free app to assist in vancomycin dosing proved to be an entertaining and enlightening journey.

Pharmacists can heighten awareness about cardiovascular health and promote heart-healthy lifestyles.

Older adults, patients with weakened immune systems, individuals living in long-term facilities, and those with underlying cardiopulmonary disease are at a higher risk of developing severe RSV infection outcomes.

Afami-cel had engineered t-cell receptor T-cells target MAGE-A4+ tumors, which are highly expressed in synovial sarcoma with HLA-A*02.

The findings suggest that further research on additional intervention methods and expanding access to hydroxyurea in Africa could benefit young patients with sickle cell disease.

A growing number of adult and pediatric patients are being diagnosed with type 2 diabetes, despite increases in care modalities.

The designation offers support in developing potential new medicines, treatment, and diagnosis to prevent rare conditions, like EoE.

Understanding differences in the various levodopa formulations and assisting with medication therapy management is a crucial role for pharmacists.

Sharon Rimon, NP, shares insights on the rectal administration of fecal microbiota therapy, highlighting its efficacy, ease of adoption in clinical practice, and benefits for patients.

An integrated strategy can simplify the development of antibody-drug conjugates.

Less manufacturing time could be the difference between a patient receiving this life-saving therapy vs not.

The transformation brought about by these technologies is akin to a revolution in health care.

On a flight home from ASHP Midyear in December, one pharmacist stepped up to the plate in a medical emergency.

Decentralized clinical trials are emerging as a method by which to address gender bias in clinical research.

Investigators determined the effectiveness of behavioral activation psychotherapy versus antidepressant medication management for inpatients with heart failure and depression.

Defective RNA editing in cells in the pancreas may spur the body to initiate an inflammatory attack against its own cells.

Inadequate levels of zinc, vitamin D, vitamin E, and vitamin B were also associated with risk of diabetes or diabetes-related complications.

Compared to embolization alone, the systemic treatment combination nearly doubled progression-free survival among patients with unresectable liver cancer.

The immune checkpoint inhibitor increased inflammation within the tumor, which may be linked to better response to nivolumab treatment.